Table 4.
CRC discussion, screening modality recommendation and compliance with CRC screening guidelines among telephone survey respondents
| Characteristics | N (%) | N (%) up-to- date with CRC screening | Univariate OR (95% CI) | Multivariate * OR (95% CI) |
|---|---|---|---|---|
| CRC screening discussed | ||||
| No | 587 (25.7) | 189 (27.3) | Reference | Reference |
| Yes | 1,851 (74.3) | 1,399 (73.8) | 7.50 (5.67–9.92) | 7.27 (5.48–9.63) |
| CRC discussion and screening modality recommendation | ||||
| No screening discussion | 587 (28.8) | 189 (27.3) | Reference | Reference |
| CRC discussed, no recommendation | 469 (23.7) | 310 (65.6) | 5.08 (3.50–7.38) | 5.46 (3.61–8.27) |
| CRC discussed and recommendation given | 1,106 (47.5) | 893 (79.0) | 10.02 (7.30–13.76) | 10.85 (7.99–14.74) |
| After CRC discussion, a screening modality was recommended | ||||
| No | 469 (33.3) | 310 (65.6) | Reference | Reference |
| Yes | 1,106 (66.7) | 893 (79.0) | 1.97 (1.40–2.77) | 2.11 (1.41–3.14) |
| Screening modality recommended | ||||
| None | 469 (33.6) | 310 (65.6) | Reference | Reference |
| Fecal occult blood only | 71 (5.1) | 43 (63.4) | 0.91 (0.42–1.94) | 1.19 (0.53–2.68) |
| Sigmoidoscopy only | 47 (2.7) | 40 (89.3) | 4.39 (1.63–11.80) | 6.67 (1.43–31.09) |
| Colonoscopy only | 940 (56.4) | 773 (80.2) | 2.12 (1.51–2.97) | 2.15 (1.43–3.22) |
| Multiple tests ** | 47 (2.4) | 40 (86.0) | 3.20 (1.36–7.56) | 2.53 (1.05–6.13) |
*
Adjusted for age, sex, race, education, income, marital status, health insurance, smoking status and having a regular healthcare provider; Telephone survey (n = 2,438; weighted population size = 38,646,812)
**
Multiple tests = recommendation of more than one colon cancer screening modality